AAAli Avanaz

Ali Avanaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ali Avanaz has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Effects of Sarcopenia on Postoperative Outcomes in Living Donor Liver Transplantation Recipients: Insights From a Turkish Single-Center Study

    by Ali Avanaz, Coşkun Aydın, Vural Taner Yilmaz, Abdullah Kisaoglu, Bora Dinc, Haydar Adanir, Bulent Aydinli

  • Open Access

    The effects of splenectomy, platelet-rich plasma (PRP) and concentrated growth factor (CGF) on liver regeneration following major hepatectomy in rats

    by Yunus Emre Sacin, Esma Kirimlioglu, Ulas Ural, Asuman Kaplan Algın, Ali Avanaz, Mustafa Ormeci, Guliz Avsar, Abdullah Kısaoglu

    Post-hepatectomy liver failure is a serious complication following liver resection and is associated with high morbidity and mortality. Platelets play a crucial role in liver regeneration due to their rich content of growth factors. However, the comparative effects of platelet-rich plasma (PRP) and concentrated growth factor (CGF) on liver regeneration remain unclear. This study aimed to evaluate and compare the effects of splenectomy (SPx), PRP, and CGF on liver regeneration and function following 70% hepatectomy in rats. Male Wistar rats were randomly divided into six groups: Control, Sham, Hepatectomy (PHx), Hepatectomy + SPx, Hepatectomy + PRP, and PHx + CGF. PRP and CGF were prepared using differential centrifugation and administered via the portal vein after hepatectomy. Liver regeneration was assessed histopathologically, immunohistochemically and biochemically on postoperative day (POD) 5. PRP treatment significantly increased Ki-67 expression, indicating enhanced hepatocyte proliferation. CGF promoted neovascularization and improved hepatocyte morphology but showed lower Ki-67 expression than PRP. SPx did not significantly enhance regeneration compared to PHx alone. Signal Transducer and Activator of Transcription 3 (STAT3) expression was highest in the PHx group, whereas the PRP and CGF groups exhibited moderate levels. PRP and CGF improved liver function biochemically, reducing bilirubin levels. Both PRP and CGF promote liver regeneration, albeit through distinct mechanisms: PRP primarily enhances cellular proliferation, whereas CGF facilitates vascularization and modulates the immune response. SPx did not confer additional benefits in this model. These findings suggest that PRP and CGF may have potential therapeutic applications in preventing post-hepatectomy liver failure.

  • Open Access

    Evaluating artificial intelligence for a focal nodular hyperplasia diagnosis using magnetic resonance imaging: preliminary findings

    by Mecit Kantarcı, Volkan Kızılgöz, Ramazan Terzi, Ahmet Enes Kılıç, Halime Kabalcı, Önder Durmaz, Nil Tokgöz, Mustafa Harman, Ayşegül Sağır Kahraman, Ali Avanaz, et al.

    Evaluating artificial intelligence for a focal nodular hyperplasia diagnosis using magnetic resonance imaging: preliminary findings - Diagnostic and Interventional Radiology


  • Delayed‐Onset Renal Allograft Compartment Syndrome in a Pediatric Kidney Transplant Recipient: The Role of Surgical Re‐Evaluation

    by Buğra Otludil, Gülşah Kaya Aksoy, Mustafa Koyun, Elif Çomak, Ali Avanaz, Bahar Akkaya, Bülent Aydınlı, Sema Akman

    Background: Renal allograft compartment syndrome (RACS) represents a rare and potentially underdiagnosed cause of allograft dysfunction, typically occurring in the immediate post‐transplant period. However, delayed‐onset RACS remains underrecognized.Methods: We present a case of a 14.5‐year‐old girl with nephronophthisis, who received a kidney transplant from her father and who was diagnosed with late‐onset renal allograft compartment syndrome on post‐transplant day 20.Results: In the post‐transplant follow‐up of this patient, the serum creatinine level increased from the 2nd day. On day 5, surgical re‐evaluation was performed as she did not respond to acute rejection therapy with prednisolone, anti‐human T‐lymphocyte immunoglobulin, and plasmapheresis. Although macroscopic examination of the allograft did not reveal any abnormalities, serum creatinine levels rapidly returned to normal after surgery. However, on the 20th day, serum creatinine started to rise again. Calcineurin toxicity and infectious causes have been ruled out. She received treatment with immunoadsorption and intravenous immunoglobulin as the second biopsy showed glomerulitis and tubulitis. Despite these treatments, the serum creatinine level increased to 6 mg/dL, and she was reassessed surgically. Although the allograft appeared normal, there was edema in the surrounding tissue. Serum creatinine levels returned to normal (0.9 mg/dL) spontaneously after surgery. So, she was diagnosed with late‐onset renal allograft compartment syndrome due to the edema surrounding the allograft and improvement observed in serum creatinine levels after fascia opening.Conclusions: RACS should be considered beyond the immediate post‐transplant period, particularly when standard interventions fail to improve graft function. Surgical exploration remains a critical diagnostic and therapeutic tool in such cases.


  • Open Access

    Demographic, Clinical and Treatment Characteristics of Patients with Hepatocellular Cancer: 10 Years of Experience of a Single Center

    by Ezgi Avanaz, Dinç Di̇nçer, Ali Avanaz, Gülsüm Özlem Elpek, Esra Çobankent Ayteki̇n, Erdem Ayik

    Primary cancers of the liver are in the 3rd place in cancer-related deaths. Hepatocellular carcinoma (HCC) accounts for approximately 80% of primary hepatic malignancies. The Barcelona Clinic Liver Cancer (BCLC) classification divides HCC into 5 stages and allocates treatments. The aim of this study is to examine the initial treatments of HCC patients in our center and compare them with the approaches in the guidelines. The data of patients diagnosed with HCC between 2006 and 2016 were recruited retrospectively. Age, gender, etiology, Child-Pugh score, BCLC stage, model for end-stage liver disease score, alpha-fetoprotein level, tumor characteristics, type of first treatment and survival time were evaluated. There were 228 men and 33 women. The mean age was 61±10.5. Of the 130 patients 77 were found on BCLC stage C. The first treatment according to BCLC stage were sorafenib in 22, resection in 16, TACE in 15, Ytrium-90 in 14, systemic chemotherapy other than sorafenib in 14, transplantation in 11, palliative treatment in 8, and ablation in 4 patients. The median survival time was 11.9 (8.1-15.9) months. One-year survival was 32%, three-year survival was 19%, and five-year survival was 16%. The management of HCC patients was performed according to more than just BCLC guidelines in our center. The high number of patients who did not receive treatment may indicate that we need to show sufficient clinical attention to Stage D patients.

  • A novel laparoscopic inguinal hernia repair technique: single-port lateral non-abdominal pre-peritoneal approach

    by Ali Avanaz

    Purpose Open and endoscopic techniques have been described for the treatment of inguinal hernia, but the gold standard treatment method is yet to be defined. Recurrence rates after inguinal hernia surgery vary between 10 and 15%, and chronic pain is seen in 10–12% of patients. This study aimed to introduce a new surgical technique called lateral non-abdominal pre-peritoneal repair for inguinal hernia surgery. Methods We recorded the data of patients’ age, gender, body mass index (BMI), prior hernia surgery, hernia side, type of hernia, postoperative complications, pain scores according to the numeric pain scale, and analgesic consumption. We performed a nearly 2 cm incision from approximately 2 cm medial and superior of the anterior superior iliac spine, then separated the peritoneum from the transverse abdominal muscle by blunt dissection, and perform the surgery by a single-port device. Results Seventeen inguinal hernias were repaired with the new technique in 14 patients. Two of the patients were female. The median age was 59, and the mean BMI was 26.8 kg/m2. The median hospital stays and time passed since the surgery was 1 day and 72 days, respectively. The mean operative time was 64 ± 29 min. The median tramadol consumption was 100 mg, and the mean paracetamol consumption was 1143 mg. The median pain score on POD 1 and current pain score was 4 and 0, respectively. Conclusions No significant complications occurred intraoperatively. We observed the pain scores were acceptable on POD 1, and excellent in postoperative follow-up. Low pain scores, low analgesic consumption, and the absence of recurrence in a newly developed procedure within the learning curve indicate that satisfactory results can be obtained.

  • Open Access

    A Novel Laparoscopic Inguinal Hernia Repair Technique: Lateral Non-abdominal Pre-peritoneal Approach Running Head: A Novel Hernia Repair Technique: LNAPP

    by Ali Avanaz

    Purpose: Open and endoscopic techniques have been described for the treatment of inguinal hernia, but the gold standard treatment method is yet to be defined. Recurrence rates after inguinal hernia surgery vary between 10-15%, and chronic pain is seen in 10-12% of patients. This study aimed to introduce a new surgical technique called lateral non-abdominal pre-peritoneal repair for inguinal hernia surgery. Methods: We recorded the data of patients’ age, gender, body mass index (BMI), prior hernia surgery, hernia side, type of hernia, postoperative complications, pain scores according to the numeric pain scale, and analgesic consumption. Results: Seventeen inguinal hernias were repaired with the new technique in 14 patients. Two of the patients were female. The median age was 59, and the mean BMI was 26.8. The median hospital stays and time passed since the surgery was 1 day, and 72 days, respectively. The mean operative time was 64 ±29 minutes. The median tramadol consumption was 100 mg, and the mean paracetamol consumption was 1143 mg. The median pain score on POD 1 and current pain score was 4 and 0, respectively. Conclusions: No significant complications occurred intraoperatively. We observed the pain scores were acceptable on POD 1, and excellent in postoperative follow-up. Low pain scores, low analgesic consumption, and the absence of recurrence in a newly developed procedure within the learning curve indicate that satisfactory results can be obtained.

  • Open Access

    Impact of COVID-19 on operating assignments in residency training of endocrine surgery: A retrospective cohort study

    by Demet Sarıdemir Ünal, Volkan Doğru, Ali Avanaz, Cumhur Arıcı


  • Open Access

    Evaluation of Overall Survival and Disease-Free Survival in Patients Receiving Liver Transplantation for Hepatocellular Carcinoma and Comparison of Living Versus Deceased Donor Liver Transplants: Results of 15 Years of Experience

    by Ali Avanaz, Haydar Adanir, Abdullah Kisaoglu, Vural Taner Yilmaz, Ezgi Avanaz, Bora Dinc, Ismail Demiryilmaz, Gülsüm Özlem Elpek, Huseyin Kocak, Bulent Aydinli

    Objective: Research comparing patients who received liver transplantation (LT) for hepatocellular carcinoma (HCC) has produced varying outcomes regarding survival and disease-free survival. The objective of this study is to determine the factors that influence the disease-free and overall survivals of those who have undergone LT for HCC and to compare the outcomes of living versus deceased donor liver transplants. Materials and Methods: We retrospectively analyzed data on patients aged 18 and above who received LT for HCC from 2006 to 2022. Patients with a follow-up period of less than 6 months and who did not meet the University of California San Francisco criteria were excluded. The data from 58 patients were analyzed. We split the patients into living donor liver transplantation (LDLT) (group 1) and deceased donor liver transplantation (DDLT) (group 2). Results: The mean age was 56 ± 8.1 years. There were 49 males and 9 females. The median of the alphafetoprotein (AFP) level and model for end-stage liver disease score was 10.1 ng/mL and 11, respectively. The 1-, 3-, 5-, and 10-year disease-free survival rates were 86%, 76.5%, 76.5%, and 76.5%, respectively. The survival rates for the same periods were 94.8%, 74.9%, 70.6%, and 67.4%. The receiver operating characteristic analysis revealed that AFP > 31.8 ng/mL and a total tumor size >3.85 cm raise the likelihood of HCC recurrence post-LT. Conclusion: Based on the current literature, the overall survival and disease-free survival rates are influenced by factors such as AFP value, total tumor number, and total tumor diameter. In our study, the AFP value and total tumor size had an impact on the recurrence of HCC, and the survival rates were comparable on LDLT and DDLT. Cite this article as: Avanaz A, Adanir H, Kisaoglu A, et al. Evaluation of overall survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma and comparison of living versus deceased donor liver transplants: results of 15 years of experience. Eurasian J Med. 2023;55(3):254-258.